PDCD4 and colorectal carcinoma: Studies have shown that miR-208b secreted by CRC cells is sufficiently delivered to receptor T cells to promote Treg amplification, tumor growth and oxaliplatin resistance by targeting programmed cell death factor 4 (PDCD4) (142).